Phase 3
Completed N=164
Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults
Source: ClinicalTrials.gov NCT00955903 ↗Enrolled (actual)
164
Serious AEs
18.9%
Results posted
Jun 2017
Primary outcomePrimary: Change in Abdominal Fat Mass — -192.6; -21.9; -275 Cubic cm
◆ Published Evidence
Established
39citations · ~10 / year
Changes in adiponectin:leptin ratio among older adults with obesity following a 12-month exercise and diet intervention.
Summary
The investigators want to determine if the benefits of weight loss outweigh the potential risk in a group of older adults. The investigators will test the hypothesis that changes in diet composition alone or in conjunction with weight loss will have a significant effect on fat stores, and as a result, improve cardiometabolic risk factors and functional status in adults 65 and older.
Linked Publications (5)
-
Changes in adiponectin:leptin ratio among older adults with obesity following a 12-month exercise and diet intervention.
-
Relative fat mass assessment estimates changes in adiposity among female older adults with obesity after a 12-month exercise and diet intervention.
-
Dietary Quality Assessed by the HEI-2010 and Biomarkers of Cardiometabolic Disease: An Exploratory Analysis.
-
Changes in Cardiometabolic Risk Among Older Adults with Obesity: An Ancillary Analysis of a Randomized Controlled Trial Investigating Exercise Plus Weight Maintenance and Exercise Plus Intentional Weight Loss by Caloric Restriction.
-
The Visceral Adiposity Index (VAI) as a predictor for metabolic syndrome in a sample of older adults with obesity.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Abdominal Fat Mass |
-192.6; -21.9; -275 | — |
| SECONDARY Cardiometabolic Risk Factors |
-7.2; 1.2; -1.2 | — |
| SECONDARY Weight Change/Maintenance |
-3.9; -1.3; -0.9 | — |
Eligibility Criteria
Inclusion Criteria
- at least 65 years of age
- BMI 27 - 42 kg/m2 - at increased health risk (taking at least 1 medication for hypertension, hyperlipidemia, or type 2 diabetes)
Exclusion Criteria
- difficulties chewing or swallowing food
- digestive diseases that may affect the ability to follow a high fiber diet
- cognitive impairment
- depression
- recent weight change (+/- 10 lbs in the last 12 months)
- poorly controlled blood pressure
- history of non-skin cancer in last 5 years
- cardiovascular disease event in past 6 months or severe pulmonary disease or renal failure
- major liver dysfunction
- current smoker or quit less than months prior
- history of prior surgical procedures for weight control or liposuction
- use of estrogen or testosterone replacement therapy
- current use of insulin or sulfonylurea agents
- current use of corticosteroids > 5 days/month on average
- current use of medications for treatment of psychosis or manic-depressive illness
- use of weight-loss medications in previous 3 months
- dependence on others for food procurement or preparation
- ischemic changes on exercise treadmill test
Data sourced from ClinicalTrials.gov (NCT00955903) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.